Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06806098 · ClinicalTrials.gov registry record · NA
Cessation Clinical Trial
A NA study of Tobacco Use Cessation, sponsored by Truth Initiative.
- Active
- Registry status
- NA
- Development phase
- 2,220
- Enrollment target
- 1
- Study location
NCT06806098: Active NA study of Tobacco Use Cessation, sponsored by Truth Initiative.
NCT06806098 is a NA study of Tobacco Use Cessation that is active but no longer recruiting, run by Truth Initiative. The registered enrollment target is 2,220 participants, above the 823-participant average among 36 other Tobacco Use Cessation trials with a reported enrollment target (170% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06806098, a NA study of Tobacco Use Cessation, is active but no longer recruiting, sponsored by Truth Initiative.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 2,220 participants
- Enrollment target
- 1
- Study location
Study Summary
The Cessation Clinical Trial will investigate the effectiveness of a digital quit tobacco program in promoting abstinence from tobacco product use compared to usual care.
Primary Outcome
30-day point prevalent abstinence from user's primary product to quit indicated at enrollment
Conditions Studied
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL Truth Initiative Digital Cessation Program
Study Locations (1)
District of Columbia
- Truth Initiative - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,220 participants |
| Start Date | 2024-12-05 |
| Est. Completion | 2025-11-30 |
| Phase | NA |
What the registry record for NCT06806098 still lists
NCT06806098 is an interventional study that assigns participants to a tested intervention. Its 2,220 participants enrollment target places it among the larger protocols in the corpus, above the 823-participant average among 36 other Tobacco Use Cessation trials with a reported enrollment target (170% higher).
The record links to 1 condition, with Tobacco Use Cessation appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.
NCT06806098 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT06806098 about?
NCT06806098 is a clinical study titled "Cessation Clinical Trial". The Cessation Clinical Trial will investigate the effectiveness of a digital quit tobacco program in promoting abstinence from tobacco product use compared to usual care.
What is the current status of trial NCT06806098?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 2,220 participants. The study started on 2024-12-05. Estimated completion is 2025-11-30.
What conditions does trial NCT06806098 study?
This clinical trial studies the following conditions: Tobacco Use Cessation.
What interventions are being tested in trial NCT06806098?
The interventions under investigation include: Usual Care (BEHAVIORAL), Truth Initiative Digital Cessation Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT06806098?
This trial is sponsored by Truth Initiative, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06806098 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Use Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06806098's enrollment target sits among peer trials
2,220 4th of 36 higher than 33 of 36 other Tobacco Use Cessation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tobacco Use Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reach Through Equitable Implementation in Utah
RECRUITING · NA
-
Development of a Smoking Cessation Video Series
RECRUITING · NA
-
Trauma-Informed Care for Smoking Cessation for Pregnancy
RECRUITING · NA
-
Mi QUIT CARE (Mile Square QUIT Community-Access-Referral-Expansion)
RECRUITING · NA
-
Comprehensive Tobacco Cessation for Cancer Patients and Survivors
RECRUITING · NA
-
Comparative Effectiveness of Mobile Health Smoking Cessation Approaches Among Underserved Patients in Primary Care
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06831929 · 2,232 participants · NA
HPV Ends Here: Increasing Uptake of the HPV Vaccine
- NCT06939803 · 2,236 participants · NA
AI-driven Clinical Decision Support to Reduce Hospital-Acquired Venous Thromboembolism: Study Protocol for the VTE-AI Randomized Trial.
- NCT05654207 · 2,200 participants · NA
WeCare: A System of Care for Black Youth
- NCT06144554 · 2,200 participants
Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI